Melatonin treatment for circadian rhythm sleep disorders
Open Access
- 1 June 2000
- journal article
- research article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 54 (3) , 381-382
- https://doi.org/10.1046/j.1440-1819.2000.00724.x
Abstract
This study investigated the effects of melatonin administration on circadian rhythm sleep disorders, and aimed to clarify clinical characteristics of melatonin responders. The subjects were 46 patients with circadian rhythm sleep disorders: 30 Delayed Sleep Phase Syndrome (DSPS) and 16 non-24 h sleep–wake syndrome (non-24). Patients took 0.3–1.0 mg of melatonin 5, 3 and 1 h before habitual bedtime. Seventeen patients responded to melatonin (12 DSPS, five non-24). Comparison of clinical background between responders and non-responders revealed that the responders were characterized by short total sleep time and later onset age of clinical symptoms.Keywords
This publication has 7 references indexed in Scilit:
- The importance of timing in melatonin administration in a blind manJournal of Pineal Research, 1992
- Melatonin Shifts Human Orcadian Rhythms According to a Phase-Response CurveChronobiology International, 1992
- Melatonin Administration to Blind People: Phase Advances and EntrainmentJournal of Biological Rhythms, 1991
- Delayed sleep phase syndrome response to melatoninThe Lancet, 1991
- Vitamin Bl2 Treatment for Sleep-Wake Rhythm DisordersSleep, 1990
- Chronotherapy: Resetting the Circadian Clocks of Patients with Delayed Sleep Phase InsomniaSleep, 1981